SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-19-004493
Filing Date
2019-08-01
Accepted
2019-08-01 17:19:54
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 a2239379zs-3.htm S-3 436038
2 EX-1.2 a2239379zex-1_2.htm EX-1.2 354428
3 EX-4.3 a2239379zex-4_3.htm EX-4.3 486022
4 EX-4.4 a2239379zex-4_4.htm EX-4.4 440638
5 EX-5.1 a2239379zex-5_1.htm EX-5.1 20568
6 EX-5.2 a2239379zex-5_2.htm EX-5.2 13107
7 EX-23.1 a2239379zex-23_1.htm EX-23.1 2597
8 G163162KSI001.JPG g163162ksi001.jpg GRAPHIC 2551
9 G163162KUI001.JPG g163162kui001.jpg GRAPHIC 2551
10 G146941.JPG g146941.jpg GRAPHIC 19580
  Complete submission text file 0001047469-19-004493.txt   1788828
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-232955 | Film No.: 19993634
SIC: 2836 Biological Products, (No Diagnostic Substances)